Learning Objectives:

  1. Become aware of how SGLT2 inhibitors work to reduce CV mortality.
  2. Become aware of how SGLT2 inhibitors may slow kidney disease progression.
  3. Become aware of adverse events from chronic use.

 

Session date: 
09/25/2017 - 5:00pm to 6:00pm CDT
Location: 
UCMC M-170
Chicago, IL 60637
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
George L. Bakris, M.D.